Aspira Women's Health

Cheers to a joyful and healthy holiday season!  As we reflect on this year and look ahead to 2025, we are thrilled to continue our journey together, making a meaningful impact on women’s health. Wishing you a wonderful holiday season and a new year filled with hope, health, and positive change.    Stay tuned for our end-of-year countdown, where we’ll highlight the most significant moments and updates of 2024!  🎉   #AspiraWomensHealth #HappyHolidays #WomensHealth #NewYearNewGoals

🔬 Tackling Ovarian Cancer Early with Aspira Women’s Health 🧬 Ovarian cancer is notoriously difficult to detect early, but Aspira Women's Health is leading the charge with groundbreaking diagnostic solutions that prioritise early detection and better outcomes. 🌟💡 Here’s how Aspira is making an impact: 🩺 OVA1 Test: Their FDA-cleared blood test assesses ovarian cancer risk before surgery, helping doctors make more informed decisions. 📊 AI-Powered Insights: Aspira integrates artificial intelligence to enhance diagnostic accuracy, providing a clearer picture of ovarian health. 🌍 Accessible Diagnostics: By making early detection tools more widely available, Aspira is empowering women to take control of their health. Aspira Women’s Health is transforming ovarian cancer care, offering hope where it’s needed most. Let’s champion innovation that saves lives! 💖 #FemTech #OvarianCancer #AspiraWomensHealth #InnovationForWomen #EarlyDetection #HealthTech #WomenInHealth

We are pleased to announce that Sandy Milligan, MD JD has stepped into the role of Interim CEO at Aspira Women's Health. With her extensive expertise and deep understanding of our technology and vision, Dr. Milligan is well-equipped to guide the execution of our long-term growth strategy as we search for a permanent successor. Read the full press release to learn more about this important leadership transition here: https://lnkd.in/dceQDZ-e #WomenInLeadership #AdvancingWomensHealth #WomensHealth #HealthcareInnovation #AspiraWomensHealth

This holiday season, we need your help to deliver comfort and hope to those in need. Your gift today will be DOUBLED, helping us provide ovarian cancer care packages filled with vital resources, support, and information. Together, we can make a difference. https://hubs.la/Q0301TFC0 #KnowOvarian

We extend our deepest gratitude to Nicole Sandford for her outstanding leadership at Aspira Women's Health. As Jannie Herchuk, Chairwoman of the Board, mentioned, Nicole’s work in stabilizing the business, building a top-tier team, and laying the groundwork for future growth has been invaluable. Thank you, Nicole, for your dedication and lasting contributions to Aspira’s journey. Read more in the full press release here: https://lnkd.in/dceQDZ-e #WomenInLeadership #HealthcareInnovation #WomensHealth #AspiraWomensHealth

For nearly three years, I have devoted almost every waking moment to the advancement of health outcomes for women as CEO of Aspira Women's Health. Unfortunately, the fight has moved much closer to home as someone I love deeply is facing the fight of lifetime. Out of respect for the privacy of my family, I will not share much more here but please keep us in your thoughts and prayers. As a cancer survivor myself, I know how important it is to have an advocate by your side to learn, research, support and love. Today I took an important step to be that advocate. I’ve always believed that a great leader is someone that builds a team that will thrive long after they have moved on. I am so, so proud of the team that I helped to bring together and I know Sandy Milligan, MD JD will lead this incredible group of professionals to even greater success! Thank you for the honor of a lifetime. #thebestinthebusiness.

We are pleased to announce the appointment of Sandy Milligan, MD JD as Interim CEO of Aspira Women’s Health. Dr. Milligan’s deep expertise and dedication to our mission make her well-equipped to lead us through this next chapter as we continue transforming women’s healthcare. We thank Nicole Sandford for her outstanding leadership in stabilizing the business, building a first-class team, and positioning the company for its next phase of growth. Nicole’s contributions to advancing ovarian cancer and endometriosis diagnostics have left a lasting impact and set a strong foundation for the future.   Together, we remain steadfast in our commitment to innovation, collaboration, and improving outcomes for women everywhere. 💙 Read the latest press release here: https://lnkd.in/dceQDZ-e   #WomensHealth #WomenInLeadership #AdvancingWomensHealth #AspiraWomensHealth

Women's health suffers from lack of comprehensive clinical research and outcomes data, which stems from decades of systemic exclusion of women from clinical trials. This historical bias has created a significant knowledge gap that directly impacts: ➡️ Research funding ➡️ Understanding of sex-specific disease manifestations ➡️ Development of targeted interventions ➡️ Narrow investment perspectives Therefore, initiatives such as Sprint for Women's Health from Advanced Research Projects Agency for Health (ARPA-H), led by Director Renee Wegrzyn, are an imperative to accelerate breakthrough innovations in women's healthcare. The program represents a strategic approach to addressing critical gaps in women's health R&D, leveraging a unique funding model to advance rigorous scientific research and deepen understanding of women's health challenges. Last week Seema Kumar and the Cure. brought together leaders from the #ARPA-H Sprint for Women's Health Program and NYC-based awardees for an inspiring evening to celebrate: Ancilia Biosciences (Alexandra Sakatos) Aspira Women's Health (Sandy Milligan, MD JD) Celmatix (Piraye Beim) Gameto (Christian Kramme, PhD) Glaucus (Elisa Riedo) and also released Cure's inaugural Women’s Health Benchmark Report, Unlocking the Opportunity: What's Needed to Innovate, Invest and Impact Women's Health (https://bit.ly/3VtCEW9). Thank you Renee Wegrzyn, Jenica Patterson Maryam Ziaei Craig Gravitz Carolee Lee Rachel Butler Jessica J. Federer Stella K. Vnook for your unwavering commitment and inspiring innovation, investments and interdisciplinary collaborations. Women's Health Access Matters Lori Frank Viq Pervaaz Komal Bajaj Kristin King-Jankiewicz, MBA Sabriya Stukes, PhD Liz Powell Wyss Institute at Harvard University Rushdy Ahmad, PhD Adama Marie Sesay Jonelle Prill-Tate Angelika Fretzen Dr. Gretchen Fougere Laurent van Lerberghe David Buller Sanj Singh Golda Arthur #womenshealth #womenshealthresearch #womenshealthdata

Join our ongoing endometriosis clinical study! We're working to advance the understanding and treatment of endometriosis. Your patients may be eligible for our study. Email us at research@aspirawh.com to collaborate! #AspiraWomensHealth #Endometriosis #Endo #EndoAwareness #EndoResearch #EndometriosisResearch #ClinicalStudy

We’re proud to be part of the Advanced Research Projects Agency for Health (ARPA-H) Sprint for Women’s Health initiative, leveraging Amazon Web Services (AWS) technology to drive progress in gynecological health. Read the full article to learn more about how AWS is helping us advance innovative solutions for women’s health here: https://lnkd.in/e88dvNPM #AspiraWomensHealth #SprintforWomensHealth #AWSreInvent